Thinking beyond
the binary

Meet the biomodal leadership team

Scientist using a pipette

We work to expand the dimensions of genetic discovery

Our culture is diverse, inquisitive, collaborative, and nimble, aiming to defy existing paradigms.

Executive leadership team

Chief Executive Officer
Chief Financial Officer
Vice President, Global Marketing & Product Management
Senior Vice President, Research & Development
Head of Global Operations
Head of Intellectual Property
Vice President, Computational Technologies
Global Head of Business Development and Customer Solutions

Board of directors

Chair of the Board
Healthcare Consultant
Director
CEO, Cellanome
Chief Executive Officer
Founder
Herchel Smith Professor of Medicinal Chemistry, University of Cambridge, Yusuf Hamied Department Of Chemistry
Director
General Partner, Google Ventures
Director
Non-Executive Director, Mabtech

Scientific advisory board

Founder
Herchel Smith Professor of Medicinal Chemistry, University of Cambridge, Yusuf Hamied Department Of Chemistry
Scientific Advisor
Head of the Epigenetics Programme, Babraham Institute
Scientific Advisor
Head of the Division of Signalling and Gene Expression, La Jolla Institute
Scientific Advisor
Group Leader of the Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre
Scientific Advisor
Vice Chancellor and President of The Chinese University of Hong Kong

Board observers

Founder & Board Observer
CSO & CVP, Microsoft
Board Observer
Managing Director, Life Sciences – EMEA & South East Asia, Temasek
Board Observer
Managing Partner, Ahren Innovation Capital
Board Observer
Managing Partner, New Science Ventures
Board Observer
General Partner, Google Ventures
Board Observer
Managing Partner, Sequoia Capital

Our investors

GV
New Science Ventures
Temasek
Syncona
Ahren

Our science

Gain greater insight into genetics and disease. biomodal’s multiomics technologies provide both genetic and epigenetic information using your existing sequencing and computing platforms.

Scientist using a pipette
Cambridge Epigenetix is now biomodal